Boston-based biotech Aprea Therapeutics $APRE started the year with a promising breakthrough therapy designation from the FDA for its lead p53 reactivating program for eprenetapopt. And it’s ending the year with a Phase III failure for the drug.
See Original Article
RESEARCH TRIANGLE PARK â United Therapeutics, which has a big operation in RTP, is paying $105 million to acquire a voucher that it says will accelerate its New Drug Application process with the FDA. The Maryland-based company (Nasdaq: UTHR)Â …
See Original Article
GM has issued a recall for 2012 and 2013 Buick Regal, 2010 through 2013 Buick Lacrosse, and 2013 Chevrolet Malibu sedans because an important suspension component may fail and cause drivers to lose control. A total of 213,128 vehicles registered in …
See Original Article
WASHINGTON â The US Food and Drug Administration issued a warning letter dated Dec. 16 to Whole Foods Market stating the retailer engaged in a pattern of receiving and offering for sale misbranded food products. Whole Foods Market, Austin, Texas, …
See Original Article
GRAND RAPIDS, Mich. (WOOD) â We are so close to Christmas, and that has some of us starting to think about what comes after the holiday! More shopping, big sales, and getting ready for the new year! So if you’re looking for a place to go on December …
See Original Article